By otakuyassine3@gmail.com 
Colgate-Palmolive (NYSE:CL – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday.
A number of other analysts have also recently weighed in on the company. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Piper Sandler initiated coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price on the stock. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. TD Cowen lowered their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $105.11.
View Our Latest Analysis on CL
Colgate-Palmolive Stock Down 0.5 %
Shares of CL traded down $0.50 during midday trading on Monday, reaching $92.94. 6,601,535 shares of the company were exchanged, compared to its average volume of 4,382,034. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $76.96 and a 1-year high of $109.30. The company has a market cap of $75.93 billion, a price-to-earnings ratio of 26.63, a P/E/G ratio of 3.31 and a beta of 0.43. The stock has a 50-day moving average price of $95.62 and a 200-day moving average price of $98.70.
Insider Buying and Selling at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.34% of the company’s stock.
Institutional Investors Weigh In On Colgate-Palmolive
Hedge funds have recently bought and sold shares of the company. Blue Trust Inc. lifted its stake in shares of Colgate-Palmolive by 139.6% in the second quarter. Blue Trust Inc. now owns 1,270 shares of the company’s stock valued at $114,000 after buying an additional 740 shares during the period. Raymond James Financial Services Advisors Inc. increased its position in shares of Colgate-Palmolive by 0.5% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 266,664 shares of the company’s stock valued at $25,877,000 after purchasing an additional 1,303 shares during the period. Continuum Advisory LLC lifted its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the period. Focus Financial Network Inc. boosted its stake in Colgate-Palmolive by 6.3% during the second quarter. Focus Financial Network Inc. now owns 5,301 shares of the company’s stock worth $527,000 after buying an additional 314 shares in the last quarter. Finally, Atria Wealth Solutions Inc. increased its holdings in Colgate-Palmolive by 14.8% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 50,452 shares of the company’s stock valued at $4,896,000 after buying an additional 6,494 shares during the period. 80.41% of the stock is currently owned by institutional investors.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
Receive News & Ratings for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.